Paradoxical Embolism 

  • Author: Igor A Laskowski, MD; Chief Editor: Vincent Lopez Rowe, MD   more...
 
Updated: May 10, 2012
 

Background

The clinical manifestations of paradoxical embolism (PDE) are nonspecific, and the diagnosis is difficult to establish. Patients with PDE may present with neurologic abnormalities or features suggesting arterial embolism. The disease starts with the formation of emboli within the venous system, which traverse a patent foramen ovale (PFO) and enter the systemic circulation.[1, 2, 3] PFOs have been found on autopsy in up to 35% of the healthy population.

PDE originates in the veins of the lower extremities and occasionally in the pelvic veins. Emboli may be of various types, such as clots, air, tumor, fat, and amniotic fluid.[4] Septic emboli have led to brain abscesses. Projectile embolization is rare (eg, from a shotgun pellet). See the image below.

The management of PDE is both medical and surgical in nature. PDE is considered the major cause of cerebral ischemic events in young patients. On rare occasions, it may occlude the pelvic aortic bifurcation. The largest documented thrombus in a PFO (impending PDE) was 25 cm in length.

PDE is confirmed by the presence of thrombus within an intracardiac defect on contrast echocardiography or at autopsy. It may be presumed in the presence of arterial embolism with no evidence of left-side circulation thrombus, deep venous thrombosis (DVT) with or without pulmonary embolism (PE), and right-to-left shunting through an intracardiac communication, commonly the PFO.[5]

Next

Pathophysiology

PDE originates from a venous thrombosis (see the image below). In most cases, the source is in the deep veins of the lower extremities; thrombosis occurs less frequently in the upper extremities than in the lower extremities. The thrombus is composed of platelets, fibrin, and, eventually, red blood cells (RBCs). It tends to propagate in the direction of the blood flow.

Paradoxical embolism. Paradoxical embolism.

Many conditions predispose individuals to increased risk for development of venous thrombosis, including the following:

  • Hypercoagulable states, such as factor V Leiden (resistance to activated protein C)
  • Antithrombin III, protein C, or protein S deficiencies
  • Antiphospholipid antibody syndrome
  • Prothrombin mutation
  • Dysfibrinogenemia

Risk factors include the following:

  • Immobilization
  • Pregnancy
  • Estrogen use
  • Previous DVT
  • Trauma
  • Neoplasms (ie, breast, pelvic malignancy, stomach, pancreas, lung)
  • Surgery (especially orthopedic, abdominal, and genitourinary procedures)
  • Thromboangiitis obliterans and homocystinuria – These 2 types of venulitis are among the least common risk factors

The intracardiac communication between the venous and arterial circulations can be in the form of a PFO, an atrial septal defect (ASD), a pulmonary arteriovenous malformation, a ventricular septal defect, an Ebstein anomaly, or a patent ductus arteriosus.

A PFO is defined as a valvelike opening between the septum primum and the septum secundum without evidence of an anatomic septal defect. PFO is significant in the etiology of PDE if associated right-to-left shunting is present. Causes of right-to-left shunting include the following:

  • Right atrial hypertension
  • Right ventricular hypertension
  • Right ventricular failure with increased end-diastolic pressure; positive-pressure ventilation
  • Positive end-expiratory pressure
  • Pulmonary hypertension from hypoxemia
  • Myocardial infarction (MI) of the right side of the heart
  • Valsalva-type maneuvers (forced expiration against a closed glottis), including urination, defecation, and sneezing

The clinical manifestations are based on complications of embolism and depend on the site of the embolus; multiorgan ischemia and infarction can occur. PE is a prerequisite for PDE. If the left pulmonary artery is occluded suddenly, the mean pulmonary artery pressure increases by 30% from the baseline. According to estimates, PE may lead to PDE only if it produces a rise in mean pulmonary artery pressure greater than 30 mm Hg, facilitating an increase in right atrial pressure above left atrial pressure that results in right-to-left shunting.

The PFO increases in size with advancing age, from a mean of 3 mm in the first decade to 6 mm in the 10th decade.

Previous
Next

Etiology

Many conditions predispose individuals to increased risk for DVT, including the following:

  • Hypercoagulable states, such as factor V Leiden (resistance to activated protein C); antithrombin III, protein C, and protein S deficiencies; antiphospholipid antibody syndrome; prothrombin mutation; and dysfibrinogenemia
  • Previous DVT
  • Immobilization
  • Pregnancy and estrogen use
  • Neoplasms (eg, of the breast, pelvis, or stomach)
  • Abdominal and thoracic surgical procedures
  • Orthopedic and genitourinary surgical procedures
  • Trauma
  • Venulitis (eg, thromboangiitis obliterans and homocystinuria)

Intracardiac communication of the venous and arterial circulations can lead to PDE and may occur via the following:

  • PFO
  • ASD
  • Pulmonary arteriovenous malformation
  • Ventricular septal defect
  • Ebstein anomaly
  • Patent ductus arteriosus
Previous
Next

Epidemiology

The actual frequency of PDE is not known, because most cases are presumed rather than proved and most cryptogenic strokes are not investigated.

PDE may be common. The incidence of stroke in the United States is approximately 500,000 per year. Of all strokes, 35-40% are cryptogenic (ie, without an identifiable source). PFOs are found in approximately 20-30% of those who sustain cryptogenic strokes. Autopsy data suggest that PFO may be present in 25-35% of the normal population. Right-to-left atrial shunts in PDE are associated with an underlying PFO in approximately 70% of case series and autopsy reports.

DVT may escape clinical detection in more than 50% of cases. Venous thrombosis may occur in more than 50% of orthopedic surgical procedures and in more than 20% of patients who undergo abdominal or thoracic surgical procedures.

The clinical findings of PDE are arterial embolic manifestations that include cerebral (40%), peripheral (50%), coronary (8%), renal (1%), and splenic (1%) ischemia or infarction. PE has been demonstrated in as many as 85% of diagnosed cases of PDE. Chronically elevated pressures of the right side of the heart are associated with 5% of PDE cases.

Age-, sex-, and race-related demographics

Elderly patients are commonly affected; PDE is not common in children. The risk of DVT is increased in the elderly population; this is correlated with the increased incidence of PDE in patients older than 55 years. Elderly patients may be at increased risk for the passage of thrombus through a PFO. The size of the PFO is usually greater in this age group than in younger populations; the average size of a PFO is 3 mm in the first decade of life versus 6 mm in the 10th decade of life.

PDEs do occur in individuals younger than 55 years when an intracardiac communication is present with risk of DVT and right-to-left atrial shunting. PFO with atrial right-to-left shunting is the most frequent cardiac finding in patients younger than 55 years with an otherwise unexplained ischemic cerebral insult or cryptogenic stroke.

The sexes are equally represented in the demographics of the disease because there is no sex-related difference in the incidence of PFO in the normal population. [#Clinical] No established differences exist across racial or ethnic groups.

Previous
Next

Prognosis

PDE generally has a good prognosis when it is not complicated. Morbidity and mortality are increased in patients with PDE and PE, depending on the size of the embolus and end-organ lodgment. When impending paradoxical embolism (PDE) occurs, the choice of treatment involves open-heart surgery.

Some p atients with PDE experience devastating outcomes with complications such as neurologic deficits, blindness, gangrene of extremities, and amputation, depending on whether the limb is salvageable or not. Organ damage may include renal infarction with eventual renal insufficiency.

Previous
Next

Patient Education

Patients on long-term anticoagulant therapy should be educated in the importance of compliance with their medication regimen for prevention of recurrent thromboembolic events. They should also be instructed to avoid vitamin K–containing foods such as green leafy vegetables (eg, spinach, broccoli, and cauliflower).

Varicose veins coexist commonly with cyanotic congenital heart disease, and these may predispose to thromboembolic phenomena. Accordingly, patients with varicose veins should avoid passive standing, should avoid crossing their legs when sitting, and should not allow their legs to be dependent.

To prevent elevation of the right atrial pressure above the left atrial pressure, which can lead to transient right-to-left shunting in patients with risk factors for PDE, Valsalva maneuvers should be avoided.

Patients should be educated regarding the adverse reactions from IV contrast agents that may occur in studies such as venography, arteriography, angiography, and cardiac catheterization (see Workup). Obtaining an informed consent after providing full explanation of the indications, implications, and complications of the procedure and the possibility of contrast-associated adverse reactions is important.

For patient education resources, see the Circulatory Problems Center, as well as Blood Clot in the Legs.

Previous
 
 
Contributor Information and Disclosures
Author

Igor A Laskowski, MD  Assistant Professor of Surgery, Section of Vascular Surgery, New York Medical College, Westchester Medical Center

Igor A Laskowski, MD is a member of the following medical societies: American College of Surgeons, American Hepato-Pancreato-Biliary Association, Peripheral Vascular Surgery Society, Society for Vascular Surgery, and Transplantation Society

Disclosure: Nothing to disclose.

Coauthor(s)

Sateesh C Babu, MD  Professor of Clinical Surgery, New York Medical College; Associate Director, Vascular Surgery, Co-chief Endovascular Surgery, Westchester Medical Center, Valhalla NY

Sateesh C Babu, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Institute of Ultrasound in Medicine, American Medical Association, Eastern Vascular Society, International Society of Endovascular Specialists, New York Academy of Sciences, Royal Society of Medicine, Society for Vascular Surgery, and Stroke Council of the American Heart Association

Disclosure: Nothing to disclose.

Oladayo Adisa Osinuga Sr, MBBS  Attending Physician, Department of Internal Medicine, Atlanta Medical Center

Oladayo Adisa Osinuga Sr, MBBS is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine and American Medical Association

Disclosure: Nothing to disclose.

Maurice Rachko  MD, Director of the Coronary Care Unit, Associate Director of the Chest Pain Unit, Beth Israel Medical Center

Maurice Rachko is a member of the following medical societies: American College of Cardiology and American College of Physicians

Disclosure: Nothing to disclose.

Klaus-Dieter Lessnau, MD, FCCP  Clinical Associate Professor of Medicine, New York University School of Medicine; Medical Director, Pulmonary Physiology Laboratory; Director of Research in Pulmonary Medicine, Department of Medicine, Section of Pulmonary Medicine, Lenox Hill Hospital

Klaus-Dieter Lessnau, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Nelson S Menezes, MD, FRCS(Edin), FACS  Assistant Professor of Surgery, Weill Cornell Medical College; Chief of Vascular Surgery, Department of Surgery, Brooklyn Hospital Center

Nelson S Menezes, MD, FRCS(Edin), FACS is a member of the following medical societies: American College of Surgeons, International Society of Endovascular Specialists, Medical Society of the State of New York, and Society for Vascular Surgery

Disclosure: Nothing to disclose.

Chief Editor

Vincent Lopez Rowe, MD  Associate Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center Program Director, Vascular Surgery Residency

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Pacific Coast Surgical Association, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Western Vascular Surgical Society

Disclosure: Nothing to disclose.

Additional Contributors

Steven J Compton, MD, FACC, FACP Director of Cardiac Electrophysiology, Alaska Heart Institute, Providence and Alaska Regional Hospitals

Steven J Compton, MD, FACC, FACP is a member of the following medical societies: Alaska State Medical Association, American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, and Heart Rhythm Society

Disclosure: Nothing to disclose.

Alan D Forker, MD Professor of Medicine, University of Missouri at Kansas City School of Medicine; Director, Outpatient Lipid Diabetes Research, MidAmerica Heart Institute of St Luke's Hospital

Alan D Forker, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, American Society of Hypertension, and Phi Beta Kappa

Disclosure: Research Grant Grant/research funds Hospital contracts to do research; I am a hospital employee with no personal profit; Speakers Bureau Honoraria Speaking and teaching

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. Cohnheim J. Thrombose und Embolie. Vorlesung ueber allgemeine Pathologie. Berlin, Hirschwald. 1877;1:134.

  2. Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. Feb 14 2012;125(6):803-12. [Medline].

  3. Eichhorn V, Bender A, Reuter DA. Paradoxical air embolism from a central venous catheter. Br J Anaesth. May 2009;102(5):717-8. [Medline].

  4. Vellayappan U, Attias MD, Shulman MS. Paradoxical embolization by amniotic fluid seen on the transesophageal echocardiography. Anesth Analg. Apr 2009;108(4):1110-2. [Medline].

  5. Mascarenhas V, Kalyanasundaram A, Nassef LA, Lico S, Qureshi A. Simultaneous massive pulmonary embolism and impending paradoxical embolism through a patent foramen ovale. J Am Coll Cardiol. Apr 14 2009;53(15):1338. [Medline].

  6. Nightingale S, Ray GS. Paradoxical embolism causing stroke and migraine. J Postgrad Med. Jul-Sep 2010;56(3):206-8. [Medline].

  7. Fischer D, Gardiwal A, Haentjes J, Klein G, Meyer GP, Drexler H, et al. Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years. Clin Res Cardiol. Apr 2012;101(4):297-303. [Medline].

  8. Kuppuswamy M, Kourliouros A, Sutherland G, Sarsam M. Complete surgical correction for impending paradoxical embolism with pulmonary embolism, tricuspid regurgitation, and atrial flutter. Heart Surg Forum. Dec 2008;11(6):E378-9. [Medline].

  9. Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, et al. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Int J Cardiol. Jan 28 2009;[Medline].

  10. Allie DE, Lirtzman MD, Wyatt CH, et al. Septic paradoxical embolus through a patent foramen ovale after pacemaker implantation. Ann Thorac Surg. Mar 2000;69(3):946-8. [Medline].

  11. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. Dec 1992;86(6):1902-8. [Medline].

  12. Cheng TO. Paradoxical embolism. Circulation. Jun 29 1999;99(25):3323. [Medline].

  13. Corrin C. Paradoxical embolism. Br Heart J. 1991;26:549.

  14. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. Nov 9 1999;100(19 Suppl):II171-5. [Medline].

  15. Devuyst G, Bogousslavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. Nov 1996;47(5):1162-6. [Medline].

  16. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. Jan 1984;59(1):17-20. [Medline].

  17. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. Apr 2000;35(5):1311-6. [Medline].

  18. Ikonomidis JS, Nisco SJ, Liang DH, et al. Paradoxical embolism of a shotgun pellet. Ann Thorac Surg. Aug 1998;66(2):562-4. [Medline].

  19. Johnson BI. Paradoxical embolism. J Clin Pathol. 1951;4:316-32.

  20. Kuhl HP, Hoffmann R, Merx MW, et al. Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial right to left shunt in patients with cerebral embolic events. J Am Coll Cardiol. Nov 15 1999;34(6):1823-30. [Medline].

  21. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. Jul 1986;112(1):141-5. [Medline].

  22. Lynch JJ, Schuchard GH, Gross CM, et al. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol. May 15 1984;53(10):1478-80. [Medline].

  23. Mas JL. Diagnosis and management of paradoxical embolism and patent formen ovale. Curr Opin Cardiol. Sep 1996;11(5):519-24. [Medline].

  24. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. Nov 1995;130(5):1083-8. [Medline].

  25. Meacham RR 3rd, Headley AS, Bronze MS, et al. Impending paradoxical embolism. Arch Intern Med. Mar 9 1998;158(5):438-48. [Medline].

  26. Nemec JJ, Marwick TH, Lorig RJ, et al. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol. Dec 1 1991;68(15):1498-502. [Medline].

  27. Sadanandan S, Sherrid MV. Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm. J Am Coll Cardiol. Jun 2000;35(7):1932-1938. [Medline].

Previous
Next
 
Paradoxical embolism.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.